5 results
  • BMS CA209-817

    A Phase IIIb/IV Safety Trial of Flat Dose Nivolumab In Combination With Ipilimumab in Participants With Non-Small Cell Lung Cancer

    Lead: Dr. Andrew Brown

    Website: https://clinicaltrials.gov/ct2/show/NCT02869789?term=CA209-817&rank=1

    For inquiries, call (973) 322-2470
    • Saint Barnabas Medical Center
  • L-07: A Phase 2 Study of Continuous Talazoparib Plus Intermittent Low-Dose Temozolomide in Patients with Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer. - NCT03672773

    Lead: Dr. Andrew Brown

    Click here for Trial Details

    For inquiries, call (973) 322-2470

    • Saint Barnabas Medical Center
  • Rutgers Cancer Institute of New Jersey - Lung Cancer Trials

    View Trials

    • Rutgers Cancer Institute of New Jersey
  • S1800A

    A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care for Patients Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNGMAP Sub-Study)

    For inquiries, call (908) 685-2481
    • RWJ University Hospital Somerset
  • The Cancer Experience Registry

    An online project where patients and caregivers participate in survey based research.

    For more information in regards to clinical research, please contact: Mary Danish, RN, Oncology Clinical Research Coordinator Mary.Danish@rwjbh.org or call (732) 923-6564.

    For inquiries, call (732) 923-6564
    • Robert Wood Johnson University Hospital